T1	CHEM 83 95	progesterona
#1	AnnotatorNotes T1	C0033308; progesterone; Hormone · Organic Chemical · Pharmacologic Substance
T2	PROC 99 138	procedimientos de reproducción asistida
T3	PROC 372 375	FIV
#2	AnnotatorNotes T3	C0015915; Fertilization in Vitro; Therapeutic or Preventive Procedure
T4	PROC 633 636	FIV
#3	AnnotatorNotes T4	C0015915; Fertilization in Vitro; Therapeutic or Preventive Procedure
T5	PROC 810 830	estimulación ovárica
T6	PROC 846 855	inducción
#4	AnnotatorNotes T6	C0857127; Induction procedure; Therapeutic or Preventive Procedure
T7	LIVB 968 975	Mujeres
#5	AnnotatorNotes T7	C0043210; Woman; Population Group | C0242665; wife; Family Group
T8	Age 979 1009	más de 18 años y menores de 42
T9	PROC 1057 1077	fecundación in vitro
#6	AnnotatorNotes T9	C0015915; Fertilization in Vitro; Therapeutic or Preventive Procedure
T10	PROC 1082 1122	transferencia diferida de un blastocisto
T11	PROC 1128 1164	screening genético preimplantacional
T12	ANAT 1203 1210	embrión
#7	AnnotatorNotes T12	C0013935; Embryo; Embryonic Structure | C0013948; Embryonic Structures; Embryonic Structure | C1305370; Entire embryo; Embryonic Structure
T13	Neg_cue 1234 1236	no
T14	ANAT 1249 1258	embriones
#8	AnnotatorNotes T14	C0013935; Embryo; Embryonic Structure | C0013948; Embryonic Structures; Embryonic Structure | C1305370; Entire embryo; Embryonic Structure
T15	Spec_cue 1277 1285	posibles
T16	Speculated 1286 1294	mosaicos
T17	Neg_cue 1299 1310	Ausencia de
T18	Negated 1311 1348	contraindicaciones médico-quirúrgicas
T19	PROC 1358 1375	punción folicular
T20	Contraindicated 1358 1375	punción folicular
T21	PROC 1388 1391	FIV
#9	AnnotatorNotes T21	C0015915; Fertilization in Vitro; Therapeutic or Preventive Procedure
T22	Neg_cue 1395 1406	Ausencia de
T23	DISO 1407 1422	miomas uterinos
#10	AnnotatorNotes T23	C0042133; Uterine Fibroids; Neoplastic Process
T24	Negated 1407 1422	miomas uterinos
T25	DISO 1532 1547	miomas uterinos
#11	AnnotatorNotes T25	C0042133; Uterine Fibroids; Neoplastic Process
T26	PROC 1624 1639	cirugía uterina
T27	DISO 1642 1659	Hipersensibilidad
#12	AnnotatorNotes T27	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T28	DISO 1662 1674	intolerancia
T29	CHEM 1706 1716	Estrógenos
#13	AnnotatorNotes T29	C0014939; estrogens; Hormone · Organic Chemical · Pharmacologic Substance
T30	CHEM 1719 1731	Progesterona
#14	AnnotatorNotes T30	C0033308; progesterone; Hormone · Organic Chemical · Pharmacologic Substance
T31	CHEM 1752 1763	excipientes
#15	AnnotatorNotes T31	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T32	CHEM 1781 1791	medicación
#16	AnnotatorNotes T32	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T33	CHEM 1846 1856	Estrógenos
#17	AnnotatorNotes T33	C0014939; estrogens; Hormone · Organic Chemical · Pharmacologic Substance
T34	Contraindicated 1846 1856	Estrógenos
T35	CHEM 1859 1871	Progesterona
#18	AnnotatorNotes T35	C0033308; progesterone; Hormone · Organic Chemical · Pharmacologic Substance
T36	Contraindicated 1859 1871	Progesterona
T37	PROC 46 73	Protección de la fase lútea
T38	PROC 191 246	estudio de parámetros predictivos de éxito reproductivo
T39	PROC 140 188	Comparación de diferentes vías de administración
T40	PROC 271 370	Estudio comparativo de diferentes pautas de cobertura gestagénica en ciclos de fecundación in vitro
T41	PROC 532 631	estudio comparativo de diferentes pautas de cobertura gestagénica en ciclos de fecundación in vitro
T42	PROC 858 881	recuperación ovocitaria
T43	PROC 1166 1171	PGT-A
T44	Negated 1249 1258	embriones
T45	PROC 1680 1694	administración
T46	Contraindicated 1820 1834	administración
T47	PROC 1820 1834	administración
T48	DISO 1570 1601	pérdidas gestacionales precoces
#19	AnnotatorNotes T48	Early Pregnancy Loss C3830362
T49	DISO 1286 1294	mosaicos
#20	AnnotatorNotes T49	Nodular embryo C0266649 
T50	PROC 773 776	FIV
T51	PROC 381 447	transferencia diferida de blastocistos genéticamente seleccionados
T52	PROC 642 708	transferencia diferida de blastocistos genéticamente seleccionados
T53	Quantifier_or_Qualifier 420 447	genéticamente seleccionados
T54	Quantifier_or_Qualifier 1190 1202	al menos, un
T55	CONC 1240 1248	incluyen
T56	CONC 1311 1329	contraindicaciones
T57	Quantifier_or_Qualifier 1593 1601	precoces
T58	Patient 968 975	Mujeres
T59	Future 1048 1053	ciclo
T60	Future 1057 1077	fecundación in vitro
T61	Future 1082 1104	transferencia diferida
T62	History_of 1570 1592	pérdidas gestacionales
T63	History_of 1624 1639	cirugía uterina
T64	History_of 1642 1659	Hipersensibilidad
T65	History_of 1662 1674	intolerancia
T66	History_of 1593 1601	precoces
